Cargando…
Refractory alveolar rhabdomyosarcoma in an 11-year-old male
Rhabdomyosarcoma (RMS) is a mesenchymal malignancy phenocopying muscle and is among the leading causes of death from childhood cancer. Metastatic alveolar rhabdomyosarcoma is the most aggressive subtype with an 8% 5-yr disease-free survival rate when a chromosomal fusion is present and a 29% 5-yr di...
Autores principales: | Ricker, Cora A., Woods, Andrew D., Simonson, William, Lathara, Melvin, Srinivasa, Ganapati, Rudzinski, Erin R., Mansoor, Atiya, Irwin, Robert G., Keller, Charles, Berlow, Noah E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7903883/ https://www.ncbi.nlm.nih.gov/pubmed/33436392 http://dx.doi.org/10.1101/mcs.a005983 |
Ejemplares similares
-
Defining an embryonal rhabdomyosarcoma endotype
por: Ricker, Cora A., et al.
Publicado: (2020) -
Defining the Extracellular Matrix of Rhabdomyosarcoma
por: Lian, Xiaolei, et al.
Publicado: (2021) -
Preclinical testing of the glycogen synthase kinase-3β inhibitor tideglusib for rhabdomyosarcoma
por: Bharathy, Narendra, et al.
Publicado: (2017) -
Functional impact of a germline RET mutation in alveolar rhabdomyosarcoma
por: Berlow, Noah E., et al.
Publicado: (2021) -
Rb1 loss modifies but does not initiate alveolar rhabdomyosarcoma
por: Kikuchi, Ken, et al.
Publicado: (2013)